Specifications
- Host Species
- Goat
- Antibody Isotype
- IgG
- Species Reactivity
- Human
- Immunogen
- Mouse myeloma cell line NS0-derived recombinant human ADAM9. Ala206-Asp697 Accession Number Q13443
- Conjugate
- Unconjugated
Applications
- Application Notes
- Western Blot 0.1 μg/mL; Immunoprecipitation 25 μg/mL; Capture 0.2-0.8 μg/mL; ELISA Detection 0.1-0.4 μg/mL
We recommend the following for sandwich ELISA (Capture - Detection):
DPABY-321 - DPABY-545
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Target
- Alternative Names
- ADAM9; ADAM metallopeptidase domain 9; MCMP; MDC9; CORD9; Mltng; disintegrin and metalloproteinase domain-containing protein 9; cone rod dystrophy 9; myeloma cell metalloproteinase; cellular disintegrin-related protein; ADAM metallopeptidase domain 9 (mel
- Entrez Gene ID
- 8754
- UniProt ID
- Q13443
References
Shintani, Y; Higashiyama, S; et al. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. CANCER RESEARCH 64:4190-4196(2004).
Singh, B; Schneider, M; et al. UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines. INTERNATIONAL JOURNAL OF CANCER 124:531-539(2009).